Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 792330 10.3389/fphar.2021.792330 Pharmacology Correction Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation Zhai et al. Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Zhai Tianyu 1 2 3 † Zhang Xiaoyu 1 † Hei Zhenyu 1 Jin Longyang 4 Han Chao 5 Ko Audrey Tsznam 6 Yu Xiaofeng 7 * Wang Jiandong 1 2 3 * Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China Shanghai Research Center of Biliary Tract Disease, Shanghai, China Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Faculty of Medicine, Imperial College London, London, United Kingdom Department of General Surgery, People’s Hospital of Gaoxin District, Suzhou, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Xiaofeng Yu, 13402682687@163.com; Jiandong Wang, wangjiandong@xinhuamed.com.cn

These authors have contributed equally to this work

This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology

 20 10 2021 2021 12 792330 10 10 2021 11 10 2021 Copyright © 2021 Zhai, Zhang, Hei, Jin, Han, Ko, Yu and Wang. 2021 Zhai, Zhang, Hei, Jin, Han, Ko, Yu and Wang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum onIsorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation by Zhai, T., Zhang, X., Hei, Z., Jin, L., Han, C., Ko, A. Z., Yu, X., and Wang J. (2021). Front. Pharmacol. 12:628621. doi: 10.3389/fphar.2021.628621 isorhamnetin gallbladder cancer tumor progression PI3K/Akt pathway apoptosis

In the published article, there was an error in the affiliations order. Affiliations 1 and 3 were interchanged, and the superscript numbers 1 and 3 in the authors’ affiliations list were updated accordingly.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.